Cardiovascular involvement in primary systemic vasculitis

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 3, 2009, Pages 419-428

  Mukhtyar, Chetan ^a   Brogan, Paul ^b   Luqmani, Raashid ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

cardiovascular disease; mortality; vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOCORTICOID; IMMUNOGLOBULIN; METHOTREXATE;

ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; AORTA ANEURYSM; AORTA ARCH SYNDROME; ATHEROGENESIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; ENDOTHELIUM; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; LOW DRUG DOSE; MORBIDITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PATIENT MONITORING; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RELAPSE; REMISSION; REVIEW; SYSTEMIC VASCULITIS;

ADOLESCENT; AORTIC ANEURYSM; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; SURVIVAL RATE; VASCULITIS; YOUNG ADULT;

EID: 66449122831     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.02.002     Document Type: Review

References (89)

1. Fries J.F., Hunder G.G., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33 8 (1990 Aug) 1135-1136
2. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 2 (1994 Feb) 187-192
3. Lanham J.G., Elkon K.B., Pusey C.D., and Hughes G.R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 63 2 (1984 Mar) 65-81
4. Watts R., Lane S., Hanslik T., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66 2 (2007 Feb) 222-227
5. Scott D.G., and Watts R.A. Classification and epidemiology of systemic vasculitis. Br J Rheumatol 33 10 (1994 Oct) 897-899
6. Ozen S., Ruperto N., Dillon M.J., et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65 7 (2006 Jul) 936-941
7. Choi H.K., Liu S., Merkel P.A., et al. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol 28 7 (2001 Jul) 1584-1590
8. Mukhtyar C., Flossmann O., Hellmich B., et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 67 7 (2008 Jul) 1004-1010
9. Reinhold-Keller E., Herlyn K., Wagner-Bastmeyer R., and Gross W.L. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53 1 (2005 Feb 15) 93-99
10. Watts R.A., Lane S., and Scott D.G. What is known about the epidemiology of the vasculitides?. Best Pract Res Clin Rheumatol 19 2 (2005 Apr) 191-207
11. Watts R.A., Jolliffe V.A., Carruthers D.M., et al. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 39 7 (1996 Jul) 1208-1212
12. Donald K.J., Edwards R.L., and McEvoy J.D. An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis. Pathology 8 2 (1976 Apr) 161-169
13. Kissel J.T., Riethman J.L., Omerza J., et al. Peripheral nerve vasculitis: immune characterization of the vascular lesions. Ann Neurol 25 3 (1989 Mar) 291-297
14. Savage C.O. The evolving pathogenesis of systemic vasculitis. Clin Med 2 5 (2002 Sep-Oct) 458-464
15. Belizna C., Duijvestijn A., Hamidou M., and Cohen Tervaert J.W. Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis 65 12 (2006 Dec) 1545-1550
16. Cid M.C. Endothelial cell biology, perivascular inflammation, and vasculitis. Cleve Clin J Med 69 Suppl. 2 (2002) SII45-SII49
17. Myllykangas-Luosujarvi R., Aho K., Kautiainen H., and Isomaki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 22 6 (1995 Jun) 1065-1067
18. Ward M.M. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42 2 (1999 Feb) 338-346
19. Bacon P.A., and Townend J.N. Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum 44 12 (2001 Dec) 2707-2710
20. Gordon M., Luqmani R.A., Adu D., et al. Relapses in patients with a systemic vasculitis. Q J Med 86 12 (1993 Dec) 779-789
21. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 31 7 (1998 Jun) 1460-1465
22. Seyahi E., Ugurlu S., Cumali R., et al. Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65 9 (2006 Sep) 1202-1207
23. Kim S.Y., Park J.H., Chung J.W., et al. Follow-up CT evaluation of the mural changes in active Takayasu arteritis. Korean J Radiol 8 4 (2007 Jul-Aug) 286-294
24. Dhillon R., Clarkson P., Donald A.E., et al. Endothelial dysfunction late after Kawasaki disease. Circulation 94 9 (1996 Nov 1) 2103-2106
25. Ikemoto Y., Ogino H., Teraguchi M., and Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 26 6 (2005 Nov-Dec) 782-786
26. McCrindle B.W., McIntyre S., Kim C., et al. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?. J Pediatr 151 3 (2007 Sep) 244-248 8 e1
27. Pilla C.B. Chronically reduced arterial distensibility in Kawasaki disease: further evidence for the beneficial effects of immunoglobulin. Circulation 102 Suppl. II (2000) 830
28. Cheung Y.F., Ho M.H., Tam S.C., and Yung T.C. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 90 11 (2004 Nov) 1281-1285
29. Cheung Y.F., Wong S.J., and Ho M.H. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child 92 1 (2007 Jan) 43-47
30. Dalla Pozza R., Bechtold S., Urschel S., et al. Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease. J Pediatr 151 3 (2007 Sep) 239-243
31. Blockmans D., de Ceuninck L., Vanderschueren S., et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55 1 (2006 Feb 15) 131-137
32. Filer A.D., Gardner-Medwin J.M., Thambyrajah J., et al. Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 62 2 (2003 Feb) 162-167
33. Booth A.D., Jayne D.R., Kharbanda R.K., et al. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation 109 14 (2004 Apr 13) 1718-1723
34. Gonzalez-Juanatey C., Llorca J., Garcia-Porrua C., et al. Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis. J Rheumatol 33 1 (2006 Jan) 74-78
35. Tso E., Flamm S.D., White R.D., et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 46 6 (2002 Jun) 1634-1642
36. Sharma B.K., Jain S., and Radotra B.D. An autopsy study of Takayasu arteritis in India. Int J Cardiol 66 Suppl. 1 (1998 Oct 1) S85-S90 (discussion S1)
37. Lehtinen A.B., Burdon K.P., Lewis J.P., et al. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. J Clin Endocrinol Metab 92 1 (2007 Jan) 345-352
38. Proven A., Gabriel S.E., Orces C., et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 49 5 (2003 Oct 15) 703-708
39. Mukhtyar C., Guillevin L., Cid M.C., et al. EULAR Recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008 Apr 15)
40. Mukhtyar C., Guillevin L., Cid M.C., et al. EULAR Recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008 Apr 15)
41. Jayne D., Rasmussen N., Andrassy K., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349 1 (2003 Jul 3) 36-44
42. Watts R.A., and Scott D.G.I. Epidemiology of vasculitis. In: Ball G.V., and Bridges Jr. S.L. (Eds). Vasculitis. 2nd edn. (2008), Oxford University Press, Oxford 7-22
43. Nuenninghoff D.M., Hunder G.G., Christianson T.J., et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48 12 (2003 Dec) 3522-3531
44. Gelsomino S., Romagnoli S., Gori F., et al. Annuloaortic ectasia and giant cell arteritis. Ann Thorac Surg 80 1 (2005 Jul) 101-105
45. Evans J.M., Bowles C.A., Bjornsson J., et al. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 37 10 (1994 Oct) 1539-1547
46. Gonzalez-Gay M.A., Garcia-Porrua C., Pineiro A., et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 83 6 (2004 Nov) 335-341
47. Evans J.M., O'Fallon W.M., and Hunder G.G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 122 7 (1995 Apr 1) 502-507
48. Gonzalez-Gay M.A., Rubiera G., Pineiro A., et al. Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study. J Rheumatol 32 3 (2005 Mar) 502-506
49. Ray J.G., Mamdani M.M., and Geerts W.H. Giant cell arteritis and cardiovascular disease in older adults. Heart 91 3 (2005 Mar) 324-328
50. Martin J.F., Kittas C., and Triger D.R. Giant cell arteritis of coronary arteries causing myocardial infarction. Br Heart J 43 4 (1980 Apr) 487-489
51. Pego-Reigosa R., Garcia-Porrua C., Pineiro A., et al. Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol 22 6 Suppl. 36 (2004) S13-S17
52. Yamada I., Shibuya H., Matsubara O., et al. Pulmonary artery disease in Takayasu's arteritis: angiographic findings. AJR Am J Roentgenol 159 2 (1992 Aug) 263-269
53. Cakar N., Yalcinkaya F., Duzova A., et al. Takayasu arteritis in children. J Rheumatol 35 5 (2008 May) 913-919
54. Panja M., Sarkar C., Kar A.K., et al. Coronary artery lesions in Takayasu's arteritis-clinical and angiographic study. J Assoc Physicians India 46 8 (1998 Aug) 678-681
55. Matsubara O., Kuwata T., Nemoto T., et al. Coronary artery lesions in Takayasu arteritis: pathological considerations. Heart Vessels Suppl 7 (1992) 26-31
56. Soto M.E., Espinola-Zavaleta N., Ramirez-Quito O., and Reyes P.A. Echocardiographic follow-up of patients with Takayasu's arteritis: five-year survival. Echocardiography 23 5 (2006 May) 353-360
57. Talwar K.K., Kumar K., Chopra P., et al. Cardiac involvement in nonspecific aortoarteritis (Takayasu's arteritis). Am Heart J 122 6 (1991 Dec) 1666-1670
58. Brogan P.A., Bose A., Burgner D., et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 86 4 (2002 Apr) 286-290
59. Newburger J.W., Takahashi M., Gerber M.A., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114 6 (2004 Dec) 1708-1733
60. Dhillon R., Newton L., Rudd P.T., and Hall S.M. Management of Kawasaki disease in the British Isles. Arch Dis Child 69 6 (1993 Dec) 631-636 (discussion 7-8)
61. Tizard E.J. Recognition and management of Kawasaki diseasee. Curr Paediatr 9 2 (1999 Jun) 97-101
62. Newburger J.W., Taubert K.A., Shulman S.T., et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4-7, 2001, Hakone, Japan. Pediatr Res 53 1 (2003 Jan) 153-157
63. Ozen S., Anton J., Arisoy N., et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145 4 (2004 Oct) 517-522
64. Chirinos J.A., Tamariz L.J., Lopes G., et al. Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol 23 2 (2004 Apr) 152-159
65. Korantzopoulos P., Papaioannides D., and Siogas K. The heart in Wegener's granulomatosis. Cardiology 102 1 (2004) 7-10
66. Aasarod K., Iversen B.M., Hammerstrom J., et al. Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 15 5 (2000 May) 611-618
67. Anderson G., Coles E.T., Crane M., et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 83 302 (1992 Jun) 427-438
68. Koldingsnes W., and Nossent J.C. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. J Rheumatol 30 1 (2003 Jan) 80-88
69. Bourgarit A., Le Toumelin P., Pagnoux C., et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 84 5 (2005 Sep) 323-330
70. Brogan P.A., Davies R., Gordon I., and Dillon M.J. Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol 17 4 (2002 Apr) 277-283
71. Brogan P.A., Shah V., and Dillon M.J. Polyarteritis Nodosa in childhood. Cleve Clin J Med 69 Suppl. 2 (2002) SII-168-SII-169
72. Cheung Y.F., Brogan P.A., Pilla C.B., et al. Arterial distensibility in children and teenagers: normal evolution and the effect of childhood vasculitis. Arch Dis Child 87 4 (2002 Oct) 348-351
73. Saulsbury F.T. Clinical update: Henoch-Schonlein purpura. Lancet 369 9566 (2007 Mar 24) 976-978
74. Gedalia A. Henoch-Schonlein purpura. Curr Rheumatol Rep 6 3 (2004 Jun) 195-202
75. Gardner-Medwin J.M., Dolezalova P., Cummins C., and Southwood T.R. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360 9341 (2002 Oct 19) 1197-1202
76. Brogan P.A. What's new in the aetiopathogenesis of vasculitis?. Pediatr Nephrol 22 8 (2007 Aug) 1083-1094
77. Dillon M.J. Henoch-Schonlein purpura: recent advances. Clin Exp Rheumatol 25 1 Suppl. 44 (2007 Jan-Feb) S66-S68
78. Ronkainen J., Nuutinen M., and Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 360 9334 (2002 Aug 31) 666-670
79. Rees L., Webb N.J.A., and Brogan P.A. Henoch Schonlein Purpura. Paediatric Nephrology (2007), Oxford University Press, Oxford p. 310-13
80. Mahr A.D., Jover J.A., Spiera R.F., et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56 8 (2007 Aug) 2789-2797
81. Brogan P.A., Shah V., Clarke L.A., et al. T cell activation profiles in Kawasaki syndrome. Clin Exp Immunol 151 2 (2008 Feb) 267-274
82. Gandhi A., and Wilson D.G. Incomplete Kawasaki disease: not to be forgotten. Arch Dis Child 91 3 (2006 Mar) 276-277
83. Maksimowicz-McKinnon K., Clark T.M., and Hoffman G.S. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 56 3 (2007 Mar) 1000-1009
84. Tada Y., Sato O., Ohshima A., et al. Surgical treatment of Takayasu arteritis. Heart Vessels Suppl 7 (1992) 159-167
85. Lagneau P., and Michel J.B. Renovascular hypertension and Takayasu's disease. J Urol 134 5 (1985 Nov) 876-879
86. Sharma S., Saxena A., Talwar K.K., et al. Renal artery stenosis caused by nonspecific arteritis (Takayasu disease): results of treatment with percutaneous transluminal angioplasty. AJR Am J Roentgenol 158 2 (1992 Feb) 417-422
87. Fields C.E., Bower T.C., Cooper L.T., et al. Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg 43 1 (2006 Jan) 64-71
88. Hellmich B., Flossmann O., Gross W.L., et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66 5 (2007 May) 605-617
89. Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 13 1 (2001 Jan) 48-55